South African COVID variant can 'break through' Pfizer vaccine: study

JERUSALEM – The coronavirus variant discovered in South Africa can "break through" Pfizer/BioNTech's COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is low and the research has not been peer-reviewed. The study, released on Saturday, compared almost 400 people who had tested positive for COVID-19,...